# NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Roche Products Ltd
- Award value: £261,970,000
- Tender value: £261,970,000
- Award date: 8 February 2023
- Published: 14 March 2023
- Contract start: 1 March 2023
- Contract end: 28 February 2025
- Stage: awarded
- Procurement category: goods
- Notice ID: 132e813f-39e2-4dce-ae80-1778abe1fa51-624078
- OCID: ocds-b5fd17-9ad5373a-6289-47c2-89c6-8c7250be3555

## Description

NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche\. Offer reference number: CM/PHR/20/5606 CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A\. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche\. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London\. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 6 months

## Related contract awards

- [Slack Enterprise Plus Licences 2026/27](/contracts/ocds-b5fd17-a5a9a52b-aebd-4eb2-9385-b1f0defaa81e): NHS England
- [Smartcards Service](/contracts/ocds-b5fd17-7ab50116-be00-4ea2-910f-ed237bdcdff6): NHS England
- [2025/NCA\.Spinal Independent Patient Safety Investigation](/contracts/ocds-b5fd17-377821fc-dde1-4f7d-8504-7b344ee7707f): NHS England
- [NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National](/contracts/ocds-b5fd17-5ea01c9a-8442-488c-bb4a-cdfa18d54a6c): NHS England
- [CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024](/contracts/ocds-b5fd17-57b54e85-da9c-4332-bb93-8a7359735da5): 02182135
- [REGN-COV2 SUPPLY AGREEMENT FOR PANDEMIC PURPOSES](/contracts/ocds-b5fd17-808eefe6-4110-42b8-8b0d-4a49deb28d40): Business Energy and Industrial Strategy

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/132e813f-39e2-4dce-ae80-1778abe1fa51-624078)